Logo

GID Ethiopia Monthly Seminar - Shared screen with speaker view
Ayele
54:43
Is the severity of second infection the same as the first infection?
Tewodros W. Liyew
56:01
Any risk with the hasty production of the vaccines especially in terms of determining side effects etc.?
Semira Abdelmenan
01:09:21
If vaccine is not the final solution, then what can be done?
Ayele
01:09:33
Why are we worried about infection when the vaccine is efficacious to disease?
Dr Lemessa
01:09:58
If majority are not immunized, could the vaccine also leads to negligence and further spread? What about herd immunity in case of COVID?
Tewodros W. Liyew
01:11:21
We know that the vaccine is going to be provided based on risk. How can we attain the required population level immunity to contain the disease in this regard?
Ayele
01:16:04
When do you think Ethiopia will join the international scientific community and be part of the vaccine development trials?
Tewodros W. Liyew
01:16:58
When is the earliest time the Ethiopia gets the vaccine?
Kalkidan Getachew
01:17:20
Thank you so much Dr.Wondessen
Elbet
01:17:35
thank you Doctor
Nebiyou F. Ayele
01:17:58
Thank you so much Dr. Wondwossen!
Hanna Y. Berhane
01:18:07
Thank you so much for a great presentation
Rahel
01:18:26
thank you Dr. wondossen!
Tewodros W. Liyew
01:18:41
Enlightening, thank you Dr. Wondossen.
Hana Sime
01:20:52
Thank you so much Dr. Wondossen for the nice , short & precise presentation .
Elsabeth Wujira
01:21:01
Thank You Dr Wondossen!
Seada
01:22:23
Thank you for your presentation. what is the purpose of the vaccine if some one vaccinated gets infected again if exposed?
Fisseha Shiferie Tadesse
01:24:54
Ethiopian Ministry of Health and Ministry of Science and Innovation have jointly announced a few months ago that they were about to start developing a vaccine/drug. Do you have any idea where we are regarding this?
Meaza Demissie
01:30:53
We have thousands of patient in Ethiopia, is there any study on the level of immunity after infection?
Semira Abdelmenan Awel
01:40:29
Thank you so much for the very nice presentation and detailed explanations!
Meaza Demissie
01:40:32
Thank you.
Amina M.
01:40:35
Very informative ! Thank you Dr. Wondwossen !
Walelegn Worku
01:40:42
Thank you, Dr. Wondosen for your wonderful presentation.
Yemane Berhane
01:41:08
thank you so much for such informative lecture.
Fisseha Shiferie Tadesse
01:41:26
Thank you so much Dr Wondwossen for your presentation and addressing my question.
Tsedey
01:41:27
thank you very much, Dr wondosen
Ayele
01:41:50
Thank you so much Dr. Wondwossen. I concur with you fully that the academia needs to be very much proactively involved in the vaccine development trial.
Dr Lemessa
01:42:07
Thanks all for organizing this event
Gadise Bekele
01:43:07
Thank you all for very informative seminar
Kalkidan Getachew
01:43:10
thank you very much
Mahlet Tadesse Admasu
01:43:20
thank you
Dr. Mahlet Aberra
01:43:51
thank you
Elsabeth Wujira
01:43:53
thank you all!